Literature DB >> 10329995

Nitric Oxide. IV. Determinants of nitric oxide protection and toxicity in liver.

J Li1, T R Billiar.   

Abstract

Whereas nitric oxide (NO) produced by constitutive endothelial NO synthase is protective to the liver, NO produced by the inducible NO synthase (iNOS) can be either toxic or protective depending on the conditions. The availability of selective iNOS inhibitors and mice lacking various NOS isoforms made it possible to begin to elucidate the precise roles of NO in the liver. Under conditions of redox stress, induced NO contributes to hepatic damage. However, in acute inflammatory conditions associated with cytokine exposure, NO acts as a potent inhibitor of apoptosis in the liver. Our current understanding of the mechanisms by which NO exerts both hepatoprotective and hepatotoxic actions is discussed in this themes article.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329995     DOI: 10.1152/ajpgi.1999.276.5.G1069

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  39 in total

1.  Effect of rifampin on production of inflammatory mediators in HepG2 liver epithelial cells.

Authors:  Yael Yuhas; Eva Berent; Shai Ashkenazi
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

Review 2.  Nitric oxide and redox regulation in the liver: Part I. General considerations and redox biology in hepatitis.

Authors:  Diana L Diesen; Paul C Kuo
Journal:  J Surg Res       Date:  2009-10-09       Impact factor: 2.192

3.  alpha-melanocyte-stimulating hormone gene transfer attenuates inflammation after bile duct ligation in the rat.

Authors:  Chien-Che Wang; Jia-Wei Lin; Liang-Ming Lee; Chien-Min Lin; Wen-Ta Chiu; Hsin-Te Pai; Kuo-Sheng Hung
Journal:  Dig Dis Sci       Date:  2007-08-04       Impact factor: 3.199

4.  Adiponectin attenuates liver fibrosis by inducing nitric oxide production of hepatic stellate cells.

Authors:  Zhixia Dong; Lin Su; Saeed Esmaili; Tristan J Iseli; Mehdi Ramezani-Moghadam; Liangshuo Hu; Aimin Xu; Jacob George; Jianhua Wang
Journal:  J Mol Med (Berl)       Date:  2015-07-09       Impact factor: 4.599

5.  Cholera toxin-sensitive GTP-binding protein-coupled activation of augmenter of liver regeneration (ALR) receptor and its function in rat kupffer cells.

Authors:  Chandrashekhar R Gandhi; Noriko Murase; Thomas E Starzl
Journal:  J Cell Physiol       Date:  2010-02       Impact factor: 6.384

Review 6.  Pathophysiological basis for antioxidant therapy in chronic liver disease.

Authors:  Jesús Medina; Ricardo Moreno-Otero
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Distribution of nitric oxide synthase in normal and cirrhotic human liver.

Authors:  Lance McNaughton; Lakshmi Puttagunta; Maria Angeles Martinez-Cuesta; Norm Kneteman; Irvin Mayers; Redwan Moqbel; Qutayba Hamid; Marek W Radomski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

8.  Interleukin-1beta contributes via nitric oxide to the upregulation and functional activity of the zinc transporter Zip14 (Slc39a14) in murine hepatocytes.

Authors:  Louis A Lichten; Juan P Liuzzi; Robert J Cousins
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-29       Impact factor: 4.052

9.  Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation.

Authors:  John D Lang; Xinjun Teng; Phillip Chumley; Jack H Crawford; T Scott Isbell; Balu K Chacko; Yuliang Liu; Nirag Jhala; D Ralph Crowe; Alvin B Smith; Richard C Cross; Luc Frenette; Eric E Kelley; Diana W Wilhite; Cheryl R Hall; Grier P Page; Michael B Fallon; J Steven Bynon; Devin E Eckhoff; Rakesh P Patel
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

10.  Inducible nitric oxide synthase deficiency impairs matrix metalloproteinase-9 activity and disrupts leukocyte migration in hepatic ischemia/reperfusion injury.

Authors:  Takashi Hamada; Sergio Duarte; Seiichiro Tsuchihashi; Ronald W Busuttil; Ana J Coito
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.